Clare Kahn
Member of the Advisory Board
pharmaceuticals
KBP BioSciences
United States of America
Biography
Dr. Kahn has extensive experience in industry with a proven leadership record in development and life-cycle. She has held senior roles growing high functioning teams in R&D, regulatory strategy and business development at the portfolio level encompassing small molecules, biologicals and vaccines. Dr. Kahn joined Pfizer in 2010 as VP Worldwide Safety and Regulatory for the $16bn Specialty Care Portfolio before assuming the Global Innovative Pharma Portfolio. In these roles she drove Pfizer’s global regulatory strategy for the President of the business encompassing vaccines, anti-infectives, inflammation, rare disease, neuroscience, pain, ophthalmology, cardiovascular, metabolic, renal and gender health.
Research Interest
phamaceutical science
